← Back to Patent Explorer
US4282143A Expired / Lapsed US ⏱️ 0.0 years remaining

Octapeptides lowering growth hormone

Assignee: Wyeth LLC
•
Filing: 1980-06-13
•
Granted: 1981-08-04
•
Expires: 2000-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polypeptides of the formula: ##STR1## in which X 1 is Phe, D-Phe or C 6 H 5 CH 2 CH 2 CO--; X 2 is Phe, Tyr, Trp, Met or Leu; X 3 is Trp or D-Trp; X 4 is Thr, Val, α-Abu or Phe; and X 5 is Phe, D-Phe or --NHCH 2 CH 2 C 6 H 5 ; the linear precursor intermediates thereof and pharmaceutically acceptable salts and amides thereof are selective inhibitors of growth hormone release without materially altering blood serum levels of glucagon or insulin. In addition, the above-described compounds are active growth hormone suppressants for periods as long as two hours.

Inventors

  • 👤 Dimitrios Sarantakis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:55
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/655; C07K14/6555; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/26

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 84 words
A compound of the formula: ##STR5## in which X 1 is Phe, D-Phe or C 6 H 5 CH 2 CH 2 CO--; X 2 is Phe, Tyr, Trp, Met or Leu; X 3 is Trp or D-Trp; X 4 is Thr, Val, α-Abu or Phe; and X 5 is Phe, D-Phe or --NHCH 2 CH 2 C 6 H 5 and the A groups are hydrogen or a direct bond between the two sulfur atoms; or a pharmaceutically acceptable salt or amide thereof.
Claim 2
Dependent Claim 84 words
A compound of the formula: ##STR5## in which X 1 is Phe, D-Phe or C 6 H 5 CH 2 CH 2 CO--; X 2 is Phe, Tyr, Trp, Met or Leu; X 3 is Trp or D-Trp; X 4 is Thr, Val, α-Abu or Phe; and X 5 is Phe, D-Phe or --NHCH 2 CH 2 C 6 H 5 and the A groups are hydrogen or a direct bond between the two sulfur atoms; or a pharmaceutically acceptable salt or amide thereof.
Claim 3
Dependent Claim 14 words
A compound of claim 1 which is ##STR6## or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 8 words
A compound of claim 1 which is ##STR7##

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-08-03 1985-02-02 1985-08-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-08-03 1989-02-02 1989-08-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-08-03 1993-02-02 1993-08-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag